Precision screening for familial hypercholesterolemia

Precision screening for familial hypercholesterolemia

Atomo’s patient finding solution has identified undiagnosed individuals in eight different diseases and conditions. Moreover, our machine learning solution has demonstrated success across EHR and healthcare claims datasets. Our most recent work has just been...
Measuring the Impact of Restrictive Prior Authorization

Measuring the Impact of Restrictive Prior Authorization

Atomo’s advanced analytics can address market access and prior authorization issues in medical conditions served by many therapies. Our most recent work has just been published! Atomo Impact Measuring the Impact of Restrictive Prior Authorization Policies with Real...